ArticleCancer research2022

An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations.

Jesse Boumelha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.